Publication | Closed Access

Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy

Prognostic EvaluationPrognostic BiomarkersMedicinePrognosisImmune Checkpoint InhibitorLong-term Clinical BenefitCancer TreatmentOncologyRadiation OncologyAnti-pd-1/-l1 TherapyLung CancerRadiologyHealth Sciences